Lupin moves court fearing tax on pre-GST stock
Lupin, like many other pharma companies, is worried that some of the stock lying in its godowns could face double taxation due to goods and services tax (GST) regulations.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news